Transparency & Aggregate Sped Spring Reporting Review 2021 | Informa Connect - CBI | 18 May 2021 | Virtual

Join us this May, after federal reporting deadlines have passed, for a timely conversation on updates in transparency and aggregate spend to allow for best practice sharing and benchmarking with industry peers. Immerse yourself in the regulations, technology, major trends, analytics and compliance insights to improve your transparency programs, both in the U.S. and around the world.

Critical Topics for Conversation:
• Government Guidance Updates Regarding OIG Speaker Programs Fraud Alert
• Lessons Learned, Challenges Overcome and Adaptations Made in 2020 to Ensure Continuity
• Data Fluctuations as a Result of the COVID-19 Pandemic
• Practical Implications of Sunshine Act Expansion and the Inclusion of Newly Covered Recipients
• Global Compliance Risks in an Interconnected World
• Dispute Management and Resolution

Who should attend?

You will benefit from this conference if you are a manager, director or executive at a bio/pharmaceutical or medical device company with responsibilities or involvement in the following areas:
• Compliance
• Ethics
• Legal
• Transparency Reporting
• Aggregate Spend
• HCP Engagement/Interactions
• Commercial
• Global Compliance/Transparency

2021 Speakers

Bobby Balles
Senior Manager, Government Accountability, Novo Nordisk

Brian Bohnenkamp
Partner, FDA & Life Sciences, King & Spalding LLP

Tammy Brintzinghoffer
Director, Global Transparency Reporting, Johnson & Johnson

Terra Buckley
Vice President, Head of Compliance Advisory Services, MedPro Systems

Emily Cunningham
Associate Principal & Transcend Lead, IQVIA

Michelle Dague
Director, Compliance, RedHill Biopharma Ltd.

Bill Friedrich, MBA
Associate Director, Compliance, Hikma Pharmaceuticals

Johan Holm
Director, U.S. Transparency, Managed Services, IQVIA

Melissa LaFrain
Director, Global Transparency Operations, AstraZeneca

Kathryn Laquidara
Conference Producer, Informa Connect

Mariko Motohashi
Associate Director, Commercial Compliance & Operations, Theravance Biopharma

Sharon Muscato
Director, Transparency & Compliance Operations, Alexion Pharmaceuticals

Chelsea Ott
Regulatory & Compliance – Senior Associate, MedPro Systems, LLC

Mohammad Ovais
CEO, qordata

Viveca Parker
Assistant U.S. Attorney, U.S. Attorney’s Office for the Eastern District of Pennsylvania

Veronika Peleshchuk Fradlin
Acting Director, Division of Data & Informatics, Centers for Medicare and Medicaid Services (CMS)

Amie Phillips Pablo
Director, Ethics and Compliance, Novo Nordisk

Nikki Reeves
Partner, FDA & Life Sciences, King & Spalding LLP

Gretchen Reyes Cseplo
Director, Ethics, Risk & Compliance, Novartis

Brian Sharkey
Director, US Commercial Compliance & Ethics, Teva Pharmaceuticals

Steven Sharobem
Assistant U.S. Attorney, The United States Attorney’s Office for the District of Massachusetts

Karen Snyder, JD
Associate Director, U.S. Compliance, MorphoSys

Frank Spender
Senior Director, Compliance Services, IQVIA

Paul Steele
Director, Transparency Reporting, Sunovion Pharmaceuticals Inc.

Risa Stokes-Grassi
Deputy Director, Federal, State & Global Disclosure Management, Bayer U.S. LLC

David Walk
Assistant U.S. Attorney, U.S. Attorney’s Office District of New Jersey

2021 Sponsors

EDUCATIONAL SPONSOR:
• IQVIA

SUPPORTING SPONSORS:
• qordata
• MediSpend
• PwC
• MedPro Systems
• Potomac River Partners
• Vector Health
• S3 Comply
• Meetings & Events International